Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

February 20, 2024

Everest Medicines to terminate deal with Providence for mRNA platform

Everest Medicines has announced plans to terminate its partnership and licence agreements with Providence Therapeutics for the development of products using its mRNA platform.

Everest Medicines to terminate deal with Providence for mRNA platform